BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10516608)

  • 41. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.
    Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E
    Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells.
    Secchiero P; Tiribelli M; Barbarotto E; Celeghini C; Michelutti A; Masolini P; Fanin R; Zauli G
    J Cell Physiol; 2005 Nov; 205(2):246-52. PubMed ID: 15887227
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chlorambucil induced apoptosis in chronic lymphocytic leukemia (CLL) and its relationship to clinical efficacy.
    Begleiter A; Lee K; Israels LG; Mowat MR; Johnston JB
    Leukemia; 1994 Apr; 8 Suppl 1():S103-6. PubMed ID: 8152273
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interleukin-2 prevents programmed cell death in chronic lymphocytic leukemia cells.
    Huang RW; Tsuda H; Takatsuki K
    Int J Hematol; 1993 Aug; 58(1-2):83-92. PubMed ID: 8219114
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia.
    Szmigielska-Kaplon A; Smolewski P; Najder M; Robak T
    Ann Hematol; 2002 Sep; 81(9):508-13. PubMed ID: 12373351
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro evaluation of B-CLL cells apoptotic responses to irradiation.
    Comby E; Andre I; Troussard X; Lebrun E; Sola B; Ballet JJ; Leporrier M
    Leuk Lymphoma; 1999 Jun; 34(1-2):159-66. PubMed ID: 10350344
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential regulation of B-cell proliferation by IL21 in different subsets of chronic lymphocytic leukemia.
    Ghalamfarsa G; Jadidi-Niaragh F; Hojjat-Farsangi M; Asgarian-Omran H; Yousefi M; Tahmasebi F; Khoshnoodi J; Razavi SM; Saboor-Yaraghi AA; Rabbani H; Jeddi-Tehrani M; Shokri F
    Cytokine; 2013 Jun; 62(3):439-45. PubMed ID: 23579027
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interleukin-5 (IL-5) increases spontaneous apoptosis of B-cell chronic lymphocytic leukemia cells in vitro independently of bcl-2 expression and is inhibited by IL-4.
    Mainou-Fowler T; Craig VA; Copplestone JA; Hamon MD; Prentice AG
    Blood; 1994 Oct; 84(7):2297-304. PubMed ID: 7919349
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fludarabine-induced apoptosis in CD19+/CD5+B-CLL cells is a direct and nurse-like-cell independent effect.
    Martinez-Lostao L; Briones J; Martinez-Gallo M; Forné I; Sierra J; Rodriguez-Sanchez JL; Juarez C
    Leuk Lymphoma; 2004 Nov; 45(11):2307-14. PubMed ID: 15512822
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD4+ T Cells are Exhausted and Show Functional Defects in Chronic Lymphocytic Leukemia.
    Allahmoradi E; Taghiloo S; Tehrani M; Hossein-Nattaj H; Janbabaei G; Shekarriz R; Asgarian-Omran H
    Iran J Immunol; 2017 Dec; 14(4):257-269. PubMed ID: 29276179
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chrysin induces apoptosis in peripheral blood lymphocytes isolated from human chronic lymphocytic leukemia.
    Zaric M; Mitrovic M; Nikolic I; Baskic D; Popovic S; Djurdjevic P; Milosavljevic Z; Zelen I
    Anticancer Agents Med Chem; 2015; 15(2):189-95. PubMed ID: 25257897
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes.
    Sherry B; Jain P; Chiu PY; Leung L; Allen SL; Kolitz JE; Rai KR; Barrientos J; Liang S; Hawtin R; Chiorazzi N
    Immunol Res; 2015 Dec; 63(1-3):216-27. PubMed ID: 26478573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J; Babusíková O
    Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of human chronic lymphocytic leukemia cells with the proteasome inhibitor bortezomib promotes apoptosis.
    Kelley TW; Alkan S; Srkalovic G; Hsi ED
    Leuk Res; 2004 Aug; 28(8):845-50. PubMed ID: 15203282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intracellular T cell cytokines in patients with B cell chronic lymphocytic leukaemia (B-CLL).
    Rossmann ED; Lewin N; Jeddi-Tehrani M; Osterborg A; Mellstedt H
    Eur J Haematol; 2002 May; 68(5):299-306. PubMed ID: 12144536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Danazol induces apoptosis and cytotoxicity of leukemic cells alone and in combination with purine nucleoside analogs in chronic lymphocytic leukemia.
    Podhorecka M; Macheta A; Chocholska S; Bojarska-Junak A; Szymczyk A; Goracy A; Dmoszynska A; Hus M
    Ann Hematol; 2016 Feb; 95(3):425-35. PubMed ID: 26692089
    [TBL] [Abstract][Full Text] [Related]  

  • 57. B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation.
    Jahrsdörfer B; Blackwell SE; Wooldridge JE; Huang J; Andreski MW; Jacobus LS; Taylor CM; Weiner GJ
    Blood; 2006 Oct; 108(8):2712-9. PubMed ID: 16809616
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytokine expression in B-CLL in relation to disease progression and in vitro activation.
    Aguilar-Santelises M; Gigliotti D; Osorio LM; Santiago AD; Mellstedt H; Jondal M
    Med Oncol; 1999 Dec; 16(4):289-95. PubMed ID: 10618692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apoptosis and secondary necrosis of lymphocytes in culture.
    Vermes I; Haanen C; Richel DJ; Schaafsma MR; Kalsbeek-Batenburg E; Reutelingsperger CP
    Acta Haematol; 1997; 98(1):8-13. PubMed ID: 9210907
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.